Dr Thiraviyam Elumalai Consultant Clinical Oncologist, Addenbrooke’s Hospital Dr Elumalai is a consultant clinical oncologist at Addenbrooke’s Hospital in Cambridge. Dr Elumalai has published several peer-reviewed articles and was involved in the recent real-world evidence (RWE) study for the treatment of nmCRPC with darolutamide.
Mr Junaid Mobeen Specialist Clinical Pharmacist Practitioner, Oncology, Nottingham University Hospital Junaid Mobeen is the Lead Oncology Pharmacist at Nottingham University Hospital and runs a pharmacy-led service for prostate cancer patients including remote patient monitoring.
Professor Amit Bahl (Chair) Consultant Clinical Oncologist, University Hospitals Bristol and Weston NHS Foundation Trust Professor Amit Bahl is a Consultant Clinical Oncologist at Bristol Cancer Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK. He is an Executive Committee member of the British Uro-oncology group and has been an expert advisor to […]